vs

Side-by-side financial comparison of Bitcoin Depot Inc. (BTM) and Core Laboratories Inc. (CLB). Click either name above to swap in a different company.

Bitcoin Depot Inc. is the larger business by last-quarter revenue ($162.5M vs $121.8M, roughly 1.3× Core Laboratories Inc.). Core Laboratories Inc. runs the higher net margin — 4.2% vs 3.4%, a 0.8% gap on every dollar of revenue. On growth, Bitcoin Depot Inc. posted the faster year-over-year revenue change (20.1% vs -1.4%). Bitcoin Depot Inc. produced more free cash flow last quarter ($2.5M vs $517.0K). Over the past eight quarters, Core Laboratories Inc.'s revenue compounded faster (-3.4% CAGR vs -4.9%).

Bitcoin Depot Inc. is one of the largest cryptocurrency ATM operators across North America. It provides retail consumers with accessible in-person kiosks to buy and sell Bitcoin and other leading digital assets, alongside online crypto purchase services via bank transfer. Its self-service kiosks are located in high-traffic retail spaces including grocery stores, gas stations and convenience stores.

Abbott Laboratories, commonly known as Abbott, is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois. The company produces pharmaceuticals for sale outside the United States, diagnostic products, nutritional products, and medical devices.

BTM vs CLB — Head-to-Head

Bigger by revenue
BTM
BTM
1.3× larger
BTM
$162.5M
$121.8M
CLB
Growing faster (revenue YoY)
BTM
BTM
+21.6% gap
BTM
20.1%
-1.4%
CLB
Higher net margin
CLB
CLB
0.8% more per $
CLB
4.2%
3.4%
BTM
More free cash flow
BTM
BTM
$2.0M more FCF
BTM
$2.5M
$517.0K
CLB
Faster 2-yr revenue CAGR
CLB
CLB
Annualised
CLB
-3.4%
-4.9%
BTM

Income Statement — Q3 FY2025 vs Q1 FY2026

Metric
BTM
BTM
CLB
CLB
Revenue
$162.5M
$121.8M
Net Profit
$5.5M
$5.1M
Gross Margin
Operating Margin
7.3%
1.5%
Net Margin
3.4%
4.2%
Revenue YoY
20.1%
-1.4%
Net Profit YoY
690.4%
EPS (diluted)
$0.08
$0.11

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BTM
BTM
CLB
CLB
Q1 26
$121.8M
Q4 25
$138.3M
Q3 25
$162.5M
$134.5M
Q2 25
$172.1M
$130.2M
Q1 25
$164.2M
$123.6M
Q4 24
$129.2M
Q3 24
$135.3M
$134.4M
Q2 24
$163.1M
$130.6M
Net Profit
BTM
BTM
CLB
CLB
Q1 26
$5.1M
Q4 25
$4.9M
Q3 25
$5.5M
$14.2M
Q2 25
$6.1M
$10.6M
Q1 25
$4.2M
$-154.0K
Q4 24
$7.4M
Q3 24
$-939.0K
$11.7M
Q2 24
$-2.6M
$9.0M
Gross Margin
BTM
BTM
CLB
CLB
Q1 26
Q4 25
20.8%
Q3 25
22.0%
Q2 25
20.3%
Q1 25
19.5%
Q4 24
17.8%
Q3 24
20.5%
Q2 24
21.2%
Operating Margin
BTM
BTM
CLB
CLB
Q1 26
1.5%
Q4 25
11.5%
Q3 25
7.3%
15.6%
Q2 25
9.2%
11.7%
Q1 25
10.8%
3.6%
Q4 24
11.0%
Q3 24
4.1%
14.7%
Q2 24
4.7%
12.3%
Net Margin
BTM
BTM
CLB
CLB
Q1 26
4.2%
Q4 25
3.6%
Q3 25
3.4%
10.6%
Q2 25
3.5%
8.2%
Q1 25
2.6%
-0.1%
Q4 24
5.7%
Q3 24
-0.7%
8.7%
Q2 24
-1.6%
6.9%
EPS (diluted)
BTM
BTM
CLB
CLB
Q1 26
$0.11
Q4 25
$0.11
Q3 25
$0.08
$0.30
Q2 25
$0.16
$0.22
Q1 25
$0.20
$0.00
Q4 24
$0.15
Q3 24
$-0.05
$0.25
Q2 24
$-0.13
$0.19

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BTM
BTM
CLB
CLB
Cash + ST InvestmentsLiquidity on hand
$59.3M
$22.8M
Total DebtLower is stronger
$67.5M
Stockholders' EquityBook value
$21.0M
$275.1M
Total Assets
$125.3M
$587.7M
Debt / EquityLower = less leverage
3.21×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BTM
BTM
CLB
CLB
Q1 26
$22.8M
Q4 25
$22.7M
Q3 25
$59.3M
$25.6M
Q2 25
$48.0M
$31.2M
Q1 25
$35.0M
$22.1M
Q4 24
$19.2M
Q3 24
$32.2M
$21.5M
Q2 24
$43.9M
$17.7M
Total Debt
BTM
BTM
CLB
CLB
Q1 26
Q4 25
$110.3M
Q3 25
$67.5M
$114.1M
Q2 25
$66.5M
$124.6M
Q1 25
$56.2M
$124.4M
Q4 24
$126.1M
Q3 24
$44.5M
$139.9M
Q2 24
$41.2M
$147.6M
Stockholders' Equity
BTM
BTM
CLB
CLB
Q1 26
$275.1M
Q4 25
$266.0M
Q3 25
$21.0M
$271.3M
Q2 25
$4.7M
$261.3M
Q1 25
$-4.6M
$253.4M
Q4 24
$246.6M
Q3 24
$-7.9M
$250.7M
Q2 24
$4.4M
$240.3M
Total Assets
BTM
BTM
CLB
CLB
Q1 26
$587.7M
Q4 25
$584.0M
Q3 25
$125.3M
$591.4M
Q2 25
$109.1M
$602.1M
Q1 25
$89.7M
$591.5M
Q4 24
$585.1M
Q3 24
$87.4M
$600.5M
Q2 24
$97.5M
$597.8M
Debt / Equity
BTM
BTM
CLB
CLB
Q1 26
Q4 25
0.41×
Q3 25
3.21×
0.42×
Q2 25
14.18×
0.48×
Q1 25
0.49×
Q4 24
0.51×
Q3 24
0.56×
Q2 24
9.27×
0.61×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BTM
BTM
CLB
CLB
Operating Cash FlowLast quarter
$6.6M
$4.0M
Free Cash FlowOCF − Capex
$2.5M
$517.0K
FCF MarginFCF / Revenue
1.6%
0.4%
Capex IntensityCapex / Revenue
2.5%
Cash ConversionOCF / Net Profit
1.20×
0.77×
TTM Free Cash FlowTrailing 4 quarters
$27.1M
$22.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BTM
BTM
CLB
CLB
Q1 26
$4.0M
Q4 25
$7.9M
Q3 25
$6.6M
$8.5M
Q2 25
$10.2M
$13.9M
Q1 25
$16.3M
$6.7M
Q4 24
$20.6M
Q3 24
$5.8M
$13.1M
Q2 24
$10.1M
$17.1M
Free Cash Flow
BTM
BTM
CLB
CLB
Q1 26
$517.0K
Q4 25
$5.0M
Q3 25
$2.5M
$6.5M
Q2 25
$9.8M
$10.4M
Q1 25
$15.9M
$3.9M
Q4 24
$17.4M
Q3 24
$-1.0M
$10.4M
Q2 24
$7.6M
$14.3M
FCF Margin
BTM
BTM
CLB
CLB
Q1 26
0.4%
Q4 25
3.6%
Q3 25
1.6%
4.8%
Q2 25
5.7%
8.0%
Q1 25
9.7%
3.1%
Q4 24
13.4%
Q3 24
-0.8%
7.7%
Q2 24
4.7%
10.9%
Capex Intensity
BTM
BTM
CLB
CLB
Q1 26
Q4 25
2.1%
Q3 25
2.5%
1.5%
Q2 25
0.2%
2.7%
Q1 25
0.2%
2.3%
Q4 24
2.5%
Q3 24
5.0%
2.0%
Q2 24
1.5%
2.2%
Cash Conversion
BTM
BTM
CLB
CLB
Q1 26
0.77×
Q4 25
1.61×
Q3 25
1.20×
0.60×
Q2 25
1.67×
1.31×
Q1 25
3.88×
Q4 24
2.78×
Q3 24
1.12×
Q2 24
1.90×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons